Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks
Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
Start Today
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
Register
AdChoices
Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time
Alerts Watchlist Portfolio

Today's Trading

Day Low 538.77
Day High 555.00
Open:554.32
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Latest
number cruncher
These 15 U.S. stocks with growing profits also score well on ESG risk
Subscriber content
inside the market
Market movers: Stocks that saw action on Monday - and why
Subscriber content
investment ideas
Renewable energy, pot stocks top losers as election results leave Wall Street hanging
u.s. business
Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern
Subscriber content
inside the market
Market movers: Stocks that saw action on Thursday - and why
Subscriber content
inside the market
Market movers: Stocks that saw action on Monday - and why
Subscriber content
Description
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

View Earnings zacks

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy
View Estimates zacks

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDF Refinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDF StockCalc

Latest Press Releases

More Stories
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
- PR Newswire - PRF - Mon Jan 25, 8:31AM CST
PR Newswire - PRF - CMTX
Mon Jan 25, 8:31AM CST
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIU, REGN, GE, MRK, and AAXN.
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
- PR Newswire - Mon Jan 25, 8:31AM CST
PR Newswire - PRNW
Mon Jan 25, 8:31AM CST
NEW YORK , Jan. 25, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIU, REGN, GE, MRK, and AAXN.
Forty of the Nation's Most Talented Young Scientists Named Finalists in Regeneron Science Talent Search 2021
- PR Newswire - Thu Jan 21, 11:01AM CST
PR Newswire - PRNW
Thu Jan 21, 11:01AM CST
TARRYTOWN, N.Y. and WASHINGTON , Jan. 21, 2021 /PRNewswire/ --  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science  (the Society) today named 40 finalists in the Regeneron Science Talent Search 2021, the nation's oldest and most prestigious science and math competition for high school seniors.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 467.00 +15.74% increase
on 01/06/21
Period Open:488.93
Price movement based on the high, low and last over the given period.
554.84 -2.58% decrease
on 01/25/21
 +51.58 (+10.55%) increase
since 12/24/20
3-Month 467.00 +15.74% increase
on 01/06/21
Period Open:579.81
Price movement based on the high, low and last over the given period.
596.80 -9.43% decrease
on 11/05/20
 -39.30 (-6.78%) decrease
since 10/23/20
52-Week 328.13 +64.73% increase
on 01/31/20
Period Open:345.28
Price movement based on the high, low and last over the given period.
664.64 -18.68% decrease
on 07/20/20
 +195.23 (+56.54%) increase
since 01/24/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies